[HTML][HTML] Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease

A Carmignani, M Battaglini, M Bartolucci, A Petretto… - Materials & Design, 2024 - Elsevier
Non-alcoholic fatty liver disease (NAFLD), or hepatic steatosis, has become one of the most
common pathologies among liver-related disorders. The rapid accumulation of fat in this …

Oncogenic impact of TONSL, a homologous recombination repair protein at the replication fork, in cancer stem cells

H Lee, S Ha, SG Choi, S Do, S Yoon, YK Kim… - International Journal of …, 2023 - mdpi.com
We investigated the role of TONSL, a mediator of homologous recombination repair (HRR),
in stalled replication fork double-strand breaks (DSBs) in cancer. Publicly available clinical …

Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate

M Jia, L Lin, H Yu, Z Dong, X Pan, X Song - Scientific Reports, 2025 - nature.com
Primary aldosteronism (PA), characterized by autonomous aldosterone overproduction, is a
major cause of secondary hypertension with significant cardiovascular complications …

Mutant RAS-driven secretome causes skeletal muscle defects in breast cancer

R Wang, AS Khatpe, B Kumar, HE Mang… - Cancer Research …, 2024 - aacrjournals.org
Cancer-induced skeletal muscle defects differ in severity between individuals with the same
cancer type. Cancer subtype-specific genomic aberrations are suggested to mediate these …

[HTML][HTML] Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer

S Dong, A Li, R Pan, J Hong, Z Wang… - Frontiers in …, 2025 - pmc.ncbi.nlm.nih.gov
Introduction Breast cancer is among the most prevalent malignant tumors globally, with
carboplatin serving as a standard treatment option. However, resistance often compromises …

ALYREF enhances breast cancer progression by regulating EZH2

SJ Jeong, JH Oh, JY Cho - Heliyon, 2024 - cell.com
Breast cancer is one of the most common malignant tumors in women worldwide. Similarly,
Canine mammary tumors (CMTs) are mostly diagnosed as spontaneous diseases in female …

[HTML][HTML] Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer

H Zhao, K Feng, J Lei, Y Shu, L Bo, Y Liu, L Wang… - Iscience, 2024 - cell.com
Somatic mutations contribute to cancer development by altering the activity of enhancers. In
the study, a total of 135 mutation-driven enhancers, which displayed significant chromatin …

TONSL promotes lung adenocarcinoma progression, immune escape and drug sensitivity

A Liang, Z Wu, T Zhuo, Y Zhu, Z Li, S Chen… - Clinical and …, 2024 - Springer
Purpose The tonsoku-like DNA repair protein (TONSL) encoded by the TONSL gene,
located on chromosome 8q24. 3, is crucial for repairing DNA double-strand breaks through …